Gail Farfel

Observer
DISC Type : ci

Director at Neurvati/GRIN Therapeutics

New York City Metropolitan Area, United States

Overview

Gail Farfel is a biotech executive and board member with over 25 years of experience in developing treatments for central nervous system disorders. With a PhD in neuropsychopharmacology from the University of Chicago, she has a proven track record in clinical development and regulatory strategy, particularly in rare neurological and neurodegenerative diseases.

Outside of her executive roles, Gail is deeply committed to patient advocacy for those affected by rare epilepsies, serving as a director for the Dravet Syndrome Foundation. In her free time, she enjoys hiking, skiing, and training her rescue dog, Sadie.

She was instrumental in the development and global regulatory approval of FINTEPLA, a key treatment for seizures associated with Dravet and Lennox-Gastaut syndromes.

Personality Overview

Value Driven

Example Seeker

Curious

They can sound friendly and charming but can quickly change gears to become inquisitive and probing.  They often ask many questions and rely heavily on information and documentation. They are generally strong communicators and are not easy to convince.

Topics They Care About

Rare Disease Advocacy
Serves on the board of the Dravet Syndrome Foundation and is passionate about advancing treatments and finding a cure for rare epilepsies.
Neurotherapeutics Development
Leads and advises on clinical development for CNS disorders, reflected in her roles at Neurvati, GRIN Therapeutics, and ASENT.
Drug Approval Process
Successfully led all product development activities to bring Fintepla to market for treating seizures in Dravet syndrome, achieving FDA and EMA approval.

Media Appearances

Gail has no verified media appearances

Work History

6-2025
Director at Neurvati/GRIN Therapeutics
6-2023
Director at Dravet Syndrome Foundation
9-2022 - 12-2023
Chief Executive Officer at ProMIS™ Neurosciences, Inc.
10-2020 - 6-2024
Director Board Of Directors at AVROBIO
2019 - 2025
Director Board Of Directors at DURECT Corporation

Education

1987 - 1993
PhD from University of Chicago
BA from University of Virginia

More Information

Social Presence :

Prographics :

Exp : 32 Location : New York City Metropolitan Area, United States Job Level : Mid-senior Designation : Director at Neurvati/GRIN Therapeutics
URL has been copied!

Insights For Selling To Gail

During A Call Or A Meeting

DO's

  • Focus on immediate action-items rather than the larger goals
  • Ask them questions to understand their needs better while staying affable
  • Persuade objectively how your product will help them achieve their goals

DONT's

  • Don’t be too objective but make sure to pad your storytelling with data points
  • Avoid making offhand commitments
  • Don’t rely excessively on your relationship with them to win the deal

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Gail is

  • Clear proof of product value matters to them, followed by others' testimonials and rapport.
  • Will you ever get a clear answer from Gail

  • They are practical yet friendly, don’t expect a clear no very often.

Insights For Deal Planning

    How fast (or slow) will Gail move?

  • They like to analyze well and then make their decisions.
  • Can Gail take some risk or not?

  • They systematically evaluate all decisions and are unlikely to take many risks.

You And Gail

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.